Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00897364 · ClinicalTrials.gov registry record

Biomarkers in the Nose, Throat, and Lung Tissue of Smokers and Non-Smokers

A clinical trial of Lung Cancer and Precancerous Condition, sponsored by University of Colorado, Denver.

Completed
Registry status
112
Enrollment target
1
Study location

NCT00897364 is a study of Lung Cancer and Precancerous Condition that has completed, run by University of Colorado, Denver. The registered enrollment target is 112 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00897364, a study of Lung Cancer and Precancerous Condition, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
112 participants
Enrollment target
1
Study location

Study Summary

RATIONALE: Studying samples of tissue from smokers and non-smokers in the laboratory may help doctors identify and learn more about biomarkers related to cancer. PURPOSE: This phase II study is looking at biomarkers in the nose, throat, and lung tissue of smokers and non-smokers.

Study Locations (1)

Colorado

  • University of Colorado Cancer Center at UC Health Sciences Center - Aurora

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2000-05
Est. Completion 2009-12-01

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT00897364

The ClinicalTrials.gov registry entry for NCT00897364 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (88% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT00897364 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT00897364 about?

NCT00897364 is a clinical study titled "Biomarkers in the Nose, Throat, and Lung Tissue of Smokers and Non-Smokers". RATIONALE: Studying samples of tissue from smokers and non-smokers in the laboratory may help doctors identify and learn more about biomarkers related to cancer. PURPOSE: This phase II study is looking at biomarkers in the nose, throat, and lung tissue of smokers and non-smokers.

What is the current status of trial NCT00897364?

This trial is currently completed. The enrollment target is 112 participants. The study started on 2000-05. Estimated completion is 2009-12-01.

What conditions does trial NCT00897364 study?

This clinical trial studies the following conditions: Lung Cancer, Precancerous Condition.

Who is sponsoring clinical trial NCT00897364?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00897364 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.